Diane Heels-Ansdell Selected Research

Dalteparin (Dalteparin Sodium)

1/2018	Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial.
9/2015	Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients.
12/2014	Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial.
11/2014	Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.
9/2013	Heparin-induced thrombocytopenia in medical surgical critical illness.
3/2013	Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness.
4/2011	Dalteparin versus unfractionated heparin in critically ill patients.
4/2011	PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan.
9/2008	Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study.
1/2008	Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diane Heels-Ansdell Research Topics

Disease

27	Critical Illness (Critically Ill) 07/2021 - 01/2005
12	Femoral Neck Fractures 01/2021 - 01/2018
12	Hemorrhage 01/2018 - 01/2007
9	Wounds and Injuries (Trauma) 06/2021 - 12/2013
9	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018 - 09/2008
9	Thrombocytopenia (Thrombopenia) 07/2017 - 04/2011
8	Thromboembolism 12/2016 - 04/2011
7	Infections 06/2021 - 01/2016
7	Pulmonary Embolism 01/2018 - 01/2008
7	Venous Thromboembolism 09/2015 - 01/2008
5	Open Fractures (Compound Fracture) 06/2021 - 06/2011
5	Tibial Fractures (Fracture, Tibial) 01/2021 - 06/2011
5	Thrombosis (Thrombus) 07/2017 - 09/2013
4	Myocardial Infarction 01/2011 - 01/2005
4	Gastroesophageal Reflux (GERD) 01/2009 - 11/2004
3	Neoplasms (Cancer) 03/2022 - 04/2014
3	Surgical Wound Infection 03/2022 - 01/2020
3	Hip Fractures (Intertrochanteric Fractures) 10/2021 - 01/2018
3	Pain (Aches) 11/2020 - 01/2018
3	Sepsis (Septicemia) 09/2014 - 06/2010
3	Myocardial Ischemia (Ischemic Heart Diseases) 03/2014 - 01/2005
3	Renal Insufficiency (Renal Failure) 06/2010 - 01/2008
3	Ischemia 09/2009 - 06/2005
2	Ventilator-Associated Pneumonia 01/2022 - 01/2021
2	Closed Fractures (Closed Fracture) 01/2021 - 11/2009
2	Clostridium Infections 01/2021 - 01/2019
2	Diarrhea 01/2021 - 01/2016
2	Osteoarthritis 11/2020 - 12/2019
2	Pneumonia (Pneumonitis) 01/2020 - 01/2018
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 09/2015
1	Healthcare-Associated Pneumonia 01/2022
1	Heterotopic Ossification (Ectopic Ossification) 01/2021
1	Atrial Fibrillation 12/2020
1	Heart Failure 12/2020
1	Hypotension (Low Blood Pressure) 12/2020
1	Frailty 01/2020
1	Nocturia 01/2020
1	COVID-19 01/2020
1	Dysbiosis 12/2018
1	Anemia 07/2017
1	Occupational Stress 01/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2017
1	Stroke (Strokes) 11/2016
1	Low Back Pain (Lumbago) 08/2015

Drug/Important Bio-Agent (IBA)

15	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 04/2011
11	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2018 - 09/2008
10	Dalteparin (Dalteparin Sodium)FDA Link 01/2018 - 01/2008
8	TroponinIBA 03/2014 - 01/2005
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2022 - 01/2019
4	AnticoagulantsIBA 07/2017 - 01/2008
3	Vitamin D FDA LinkGeneric 10/2021 - 06/2020
3	Pharmaceutical PreparationsIBA 01/2020 - 09/2008
3	Proton Pump InhibitorsIBA 01/2018 - 11/2004
3	CreatinineIBA 01/2018 - 01/2008
3	Esomeprazole (Nexium)FDA Link 01/2007 - 11/2004
2	Opioid Analgesics (Opioids)IBA 11/2020 - 08/2015
2	SolutionsIBA 01/2020 - 01/2006
2	Serotonin (5 Hydroxytryptamine)IBA 06/2014 - 09/2013
2	Troponin T (Troponin T1)IBA 03/2014 - 01/2011
2	trans-crotonin (CTN)IBA 09/2009 - 12/2006
1	Polyethylene (Polythene)IBA 03/2021
1	Natriuretic PeptidesIBA 12/2020
1	pro-brain natriuretic peptide (1-76)IBA 12/2020
1	molnupiravirIBA 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	Aligeron (AS 2)IBA 01/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	ChlorhexidineIBA 01/2020
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2020
1	nirmatrelvir and ritonavir drug combinationIBA 01/2020
1	Sucralfate (Carafate)FDA LinkGeneric 01/2018
1	Prednisolone (Predate)FDA LinkGeneric 01/2018
1	Nicotine FDA Link 01/2017
1	PlacebosIBA 10/2016
1	salicylhydroxamic acid (SHAM)IBA 10/2016
1	Soaps (Soap)IBA 12/2015
1	Saline SolutionIBA 12/2015

Therapy/Procedure

10	Critical Care (Surgical Intensive Care) 12/2016 - 01/2007
7	Intramedullary Fracture Fixation 01/2021 - 11/2009
6	Hemiarthroplasty 01/2021 - 12/2019
6	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2021 - 12/2019
5	Length of Stay 01/2022 - 12/2006
5	Arthroplasty 01/2021 - 11/2020
4	Artificial Respiration (Mechanical Ventilation) 01/2022 - 04/2014
4	Therapeutics 01/2017 - 01/2006
3	Reoperation 01/2021 - 01/2018
2	Debridement 06/2021 - 01/2018
2	Orthopedic Procedures 01/2020 - 12/2013
2	Aftercare (After-Treatment) 01/2007 - 01/2005
1	Prostheses and Implants (Prosthesis) 03/2022
1	Terminal Care (Care, Terminal) 07/2021
1	Drug Therapy (Chemotherapy) 03/2021
1	Limb Salvage 03/2021
1	Perioperative Care 12/2020
1	Fracture Fixation 06/2020
1	Platelet Transfusion (Blood Platelet Transfusions) 07/2017
1	Conservative Treatment 11/2016
1	Contraindications 01/2016
1	Physical Therapy Modalities (Physical Therapy Technique) 08/2015